These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19697416)

  • 1. Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adults.
    Van Damme P; von Sonnenburg F; Hatz C; Hoet B; Lefevre I; Leyssen M
    J Med Virol; 2009 Oct; 81(10):1710-5. PubMed ID: 19697416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of HBV vaccine during stated shelf-life.
    Gloriani NG; Srinivasa K; Bock HL; Hoet B
    Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):876-82. PubMed ID: 21073062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.
    Kulkarni PS; Raut SK; Patki PS; Phadke MA; Jadhav SS; Kapre SV; Dhorje SP; Godse SR
    Vaccine; 2006 Apr; 24(17):3457-60. PubMed ID: 16530299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update: expanded availability of thimerosal preservative-free hepatitis B vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jul; 49(28):642, 651. PubMed ID: 10926308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.
    McMahon BJ; Dentinger CM; Bruden D; Zanis C; Peters H; Hurlburt D; Bulkow L; Fiore AE; Bell BP; Hennessy TW
    J Infect Dis; 2009 Nov; 200(9):1390-6. PubMed ID: 19785526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
    Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
    Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
    Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
    J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
    Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
    Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Gabbuti A; Romanò L; Blanc P; Meacci F; Amendola A; Mele A; Mazzotta F; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3129-32. PubMed ID: 17291637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of Twinrix in older adults: a critical analysis.
    Stoffel M; Lievens M; Dieussaert I; Martin I; André F
    Expert Rev Vaccines; 2003 Feb; 2(1):9-14. PubMed ID: 12901592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants.
    Hu Y; Wu Q; Xu B; Zhou Z; Wang Z; Zhou YH
    Vaccine; 2008 Nov; 26(48):6064-7. PubMed ID: 18812198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V; Nandakumar S; Shanmugam S; Shankar EM; Thangavel S; Kulkarni PS; Thyagarajan SP
    Pediatr Infect Dis J; 2007 Nov; 26(11):1038-41. PubMed ID: 17984812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults.
    Rebedea I; Diaconescu IG; Bach D; Bartelsen O; Arndtz N
    Vaccine; 2006 Jun; 24(25):5320-6. PubMed ID: 16707195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
    Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago.
    Wang LY; Lin HH
    Vaccine; 2007 Oct; 25(41):7160-7. PubMed ID: 17707557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements in international units of antibody to hepatitis B surface antigen(anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA).
    Ogata N
    Rinsho Byori; 2006 Apr; 54(4):340-3. PubMed ID: 16722452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
    Van der Wielen M; Van Damme P; Chlibek R; Smetana J; von Sonnenburg F
    Vaccine; 2006 Jun; 24(26):5509-15. PubMed ID: 16725234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.